Millenet, Sabina
Laucht, Manfred
Hohm, Erika
Jennen-Steinmetz, Christine
Hohmann, Sarah
Schmidt, Martin H.
Esser, Günter
Banaschewski, Tobias
Brandeis, Daniel
Zohsel, Katrin
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft
Article History
Received: 10 January 2017
Accepted: 15 February 2018
First Online: 1 March 2018
Compliance with ethical standards
:
: Dr. Banaschewski served in an advisory or consultancy role for Actelion, Hexal Pharma, Lilly, Lundbeck, Medice, Novartis, and Shire. He received conference support or speaker’s fees from Lilly, Medice, Novartis, and Shire. He has been involved in clinical trials conducted by Shire and Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, and Oxford University Press. The present work is unrelated to the above grants and relationships. All other authors declare that they have no potential conflict of interest.